AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Hypopigmentation Disorder Treatment Market Analysis & Trends: Forecast 2018-2026 - ResearchAndMarkets.com

December 30, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Dec 30, 2019--

The “Hypopigmentation Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026” report has been added to ResearchAndMarkets.com’s offering.

This report analyzes the current and future scenario of the global hypopigmentation disorder treatment market. Increase in patient population with hypopigmentation disorders, growth of the pharmaceutical industry, improvement in health care infrastructure, and increase in the number of clinical trials are projected to be the major drivers of the global market during the forecast period.

The global hypopigmentation disorder treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global hypopigmentation disorder treatment market.

Key Topics Covered:

1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights

2. Assumptions and Research Methodology

2.1. Assumptions and Acronyms Used

2.2. Research Methodology

3. Executive Summary

4. Market Overview

4.1. Market Overview

4.2. Global Hypopigmentation Disorders Treatment Market Analysis

4.3. Global Hypopigmentation Disorders Treatment Market Overview

4.4. Porter’s Five Forces Analysis

4.5. Pipeline Analysis

4.6. Key Partnership & Acquisitions

4.7. Disease Prevalence and Incidence: Global Overview

4.8. Regulatory Scenario

5. Market Dynamics

5.1. Drivers and Restraints Snapshot Analysis

5.2. Drivers

5.3. Restraints

5.4. Opportunities

5.5. Key Trends

6. Global Hypopigmentation Disorders Treatment Market Analysis, by Treatment

6.1. Introduction

6.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by Treatment

6.3. Global Hypopigmentation Disorders Treatment Market Forecast, by Treatment

6.4. Global Hypopigmentation Disorders Treatment Market Analysis, by Treatment

6.4.1. Topical Drugs

6.4.2. Laser Therapy

6.4.3. Chemical Peels

6.4.4. Microdermabrasion

6.4.5. Others (phototherapy, etc.)

6.5. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment

7. Global Hypopigmentation Disorders Treatment Market Analysis, by Disease Indication

7.1. Introduction

7.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by Disease Indication

7.3. Global Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication

7.4. Global Hypopigmentation Disorders Treatment Market Analysis, by Disease Indication

7.4.1. Vitiligo

7.4.2. Albinism

7.4.3. Others

7.5. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis

8. Global Hypopigmentation Disorders Treatment Market Analysis, by End-user

8.1. Introduction

8.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by End-user

8.3. Global Hypopigmentation Disorders Treatment Market Forecast, by End-user

8.4. Global Hypopigmentation Disorders Treatment Market Analysis, by End-user

8.4.1. Hospitals

8.4.2. Aesthetic Clinics & Dermatology Centers

8.4.3. Others

8.5. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by End-user

9. Global Hypopigmentation Disorders Treatment Market Analysis, by Region

9.1. Global Market Scenario

9.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by Region

9.3. Global Hypopigmentation Disorders Treatment Market Forecast, by Region

9.3.1. North America

9.3.2. Europe

9.3.3. Asia Pacific

9.3.4. Latin America

9.3.5. Middle East & Africa

9.4. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Region

10. North America Hypopigmentation Disorders Treatment Market Analysis

10.1. North America Hypopigmentation Disorders Treatment Market Analysis

10.2. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Country

10.3. North America Hypopigmentation Disorders Treatment Market Forecast, by Country

10.4. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Treatment

10.5. North America Hypopigmentation Disorders Treatment Market Forecast, by Treatment

10.6. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Disease Indication

10.7. North America Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication

10.8. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by End-user

11. Europe Hypopigmentation Disorders Treatment Market Analysis

12. Asia Pacific Hypopigmentation Disorders Treatment Market Analysis

13. Latin America Hypopigmentation Disorders Treatment Market Analysis

14. Middle East & Africa Hypopigmentation Disorders Treatment Market Analysis

15. Competition Landscape

15.1. Hypopigmentation Disorders Treatment Market Share Analysis, by Company

15.2. Competition Matrix

15.3. Company Profile

15.3.1. Allergan

15.3.2. SkinCeuticals

15.3.3. Pierre Fabre

15.3.4. Episciences, Inc.

15.3.5. Rxi Pharmaceutical Corporation

15.3.6. Obagi Cosmeceuticals LLC (Obagi Medical)

15.3.7. Alvogen

For more information about this report visit https://www.researchandmarkets.com/r/13419y

View source version on businesswire.com:https://www.businesswire.com/news/home/20191230005168/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 12/30/2019 07:40 AM/DISC: 12/30/2019 07:40 AM

http://www.businesswire.com/news/home/20191230005168/en